The role of pyroptosis in cancer: key components and therapeutic potential

Zixi Liu1, Simiao Xu2, Lin Chen1

  • 1Department of Biliary-Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, Hubei, 430030, China.

Insights

Pyroptosis, a programmed cell death process, is crucial in cancer development. Understanding its dual role in inhibiting or promoting tumors is key for developing new pyroptosis-targeted cancer therapies.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Pyroptosis is a lytic, inflammatory programmed cell death mediated by gasdermin proteins, typically initiated by inflammasomes.
  • The inflammasome pathway is vital for eliminating pathogens and cancerous cells during cellular injury.
  • Gasdermin proteins orchestrate pyroptosis by forming pores in the cell membrane, releasing inflammatory mediators.

Purpose of the Study:

  • To provide an overview of pyroptosis and its role in cancer.
  • To examine the relationship between pyroptosis and tumor development.
  • To highlight the potential of pyroptosis-targeted therapies for cancer treatment.

Main Methods:

  • This review synthesizes existing research on pyroptosis and its implications in oncology.
  • It analyzes the molecular mechanisms underlying pyroptosis initiation and execution.
  • The study explores the dual role of pyroptosis in cancer progression and inhibition.

Main Results:

  • Pyroptosis plays a critical role in controlling cancer development.
  • The gasdermin-mediated cell death process exhibits a dual nature, potentially inhibiting or promoting tumor growth.
  • Specific cellular conditions dictate whether pyroptosis acts as an anti-cancer or pro-cancer mechanism.

Conclusions:

  • Pyroptosis has a complex, dual impact on tumor initiation and progression.
  • Targeting pyroptosis offers a promising avenue for novel cancer therapeutics.
  • Further research into the nuanced effects of pyroptosis can guide the development of effective cancer treatments.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K